Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of quinoline-3-carboxamide compounds for inhibiting the production of tumor necrosis factor (TNF) and/or for the treatment of septic shock

Use of quinoline-3-carboxamide compounds for inhibiting the production of tumor necrosis factor (TNF) and/or for the treatment of septic shock

US Patent 5776947 · Granted Jul 7, 1998

Estimated economic value: $60,265,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for inhibiting diazepam binding protein2025
Methods for weight reduction2024
Methods and pharmaceutical compositions for modulating autophagy in a subject in2021
Simultaneous detection of cannibalism and senescence as prognostic marker for ca2021
Methods and pharmaceutical compositions for treating human immunodeficiency viru2018
Combined therapy for cystic fibrosis2017
Simultaneous detection of cannibalism and senescence as prognostic marker for ca2017
Combined therapy for cystic fibrosis2015
Method of treatment for immunogenic treatment resistant cancer2014
Compounds and uses thereof to induce an immunogenic cancer cell death in a subje2014
Toll like receptor 4 dysfunction and the biological applications thereof2013
Compounds regulating calreticulin, KDEL receptor and/or Erp-57 cell surface expo2012